SIGHT SCIENCES, INC.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | Apr 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $23.4M | — | $19.7M | — | — | — | $19.9M |
| Cost of Revenue | — | $2.0M | — | $2.7M | — | — | — | $2.7M |
| Gross Profit | — | $21.4M | — | $17.0M | — | — | — | $17.2M |
| Gross Margin | — | 91.4% | — | 86.2% | — | — | — | 86.4% |
| Operating Expenses | ||||||||
| Research & Development | — | $2.5M | — | $2.5M | — | — | — | $3.4M |
| SG&A Expense | — | $22.8M | — | $26.8M | — | — | — | $21.8M |
| Operating Income | — | $-3.9M | — | $-12.4M | — | — | — | $-7.9M |
| Operating Margin | — | -16.6% | — | -63.0% | — | — | — | -39.7% |
| Interest Expense | — | $1.3M | — | $1.3M | — | — | — | $1.3M |
| Pretax Income | — | $-4.4M | — | $-13.0M | — | — | — | $-8.2M |
| Income Tax Expense | — | $28.0K | — | $11.0K | — | — | — | $-79.0K |
| Net Income | — | $-4.4M | — | $-13.0M | — | — | — | $-8.2M |
| Net Margin | — | -19.0% | — | -65.9% | — | — | — | -41.0% |
| EPS (Basic) | — | $-0.08 | — | $-0.24 | — | — | — | $-0.16 |
| EPS (Diluted) | — | $-0.08 | — | $-0.24 | — | — | — | $-0.16 |
| Shares Outstanding (Basic) | 55.1M | 54.5M | 54.4M | 53.9M | 54.0M | 53.5M | 52.9M | 52.4M |
| Shares Outstanding (Diluted) | 55.1M | 54.5M | 54.4M | 53.9M | 54.0M | 53.5M | 52.9M | 52.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |